{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:20:09Z","timestamp":1791390009120,"version":"4.3.3"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>This study aims to investigate the factors influencing the first-line treatment response in children with primary immune thrombocytopenia (ITP) and to evaluate the predictive value of these indicators for therapeutic outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 140 pediatric patients diagnosed with ITP at the Pediatrics Department of the First Affiliated Hospital of Shihezi University, between June 2022 and December 2024, were enrolled. Patients were grouped according to the type of first-line treatment and treatment response. Laboratory tests such as platelet parameters, P-glycoprotein (P-gp), T lymphocyte subsets, immunoglobulins, and complements were collected and analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Multivariate logistic regression analysis identified elevated P-gp and platelet-to-lymphocyte ratio (PLR), decreased of CD4<jats:sup>+<\/jats:sup>\/CD8<jats:sup>+<\/jats:sup> ratio and complement 3 (C3) levels as independent risk factors for glucocorticosteroid (GC) treatment failure in children with ITP. Receiver operating characteristic curve (ROC) analysis identified the areas under the curve (AUCs) were 0.772, 0.763, 0.731, and 0.731. The combined model yielded an AUC of 0.919. Elevated PLR and immunoglobulin G (IgG) were independent risk factors for intravenous immune globulin (IVIG) treatment failure.ROC analysis showed that PLR and IgG were predictive of IVIG treatment failure in children with ITP. The AUCs were 0.769 and 0.722, respectively. The combined model yielded an AUC of 0.810.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Elevated P-gp and PLR, along with reduced CD4<jats:sup>+<\/jats:sup>\/CD8<jats:sup>+<\/jats:sup> ratio and C3 levels, are independent risk factors for GC treatment failure in children with ITP. For IVIG therapy, increased PLR and IgG levels are associated with poor response. These indicators demonstrate predictive value for first-line treatment efficacy, with combined marker analysis offering superior predictive accuracy compared to individual indicators.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2025.1679463","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T04:10:47Z","timestamp":1759464647000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Study on the influencing factors of the first-line treatment response to primary immune thrombocytopenia in children"],"prefix":"10.3389","volume":"13","author":[{"given":"Bihan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaodao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1055\/s-0039-1683416","article-title":"Epidemiology and clinical manifestations of immune thrombocytopenia","volume":"39","author":"Kohli","year":"2019","journal-title":"Hamostaseologie"},{"key":"B2","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3760\/cma.j.cn112140-20210509-00397","article-title":"Adapted guideline for the diagnosis and treatment of primary immune thrombocytopenia for Chinese children (2021)","volume":"59","year":"2021","journal-title":"Chin J Pediatr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.13558\/j.cnki.issn1672-3686.2019.012.002","article-title":"Diagnosis and treatment guidelines for primary immune thrombocytopenia in children (2019)","volume":"17","year":"2019","journal-title":"Clin Educ Gen Pract"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3969\/j.issn.1009-5519.2022.10.001","article-title":"Application of immature platelet fraction in the differentiating thrombocytopenic disorders in children","volume":"38","author":"Wang","year":"2022","journal-title":"J Mod Med Health"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2304486","DOI":"10.1080\/16078454.2024.2304486","article-title":"Lymphocyte subpopulations: a potential predictor of a response in patients with immune thrombocytopenia","volume":"29","author":"\u017dib\u0159idov\u00e1","year":"2024","journal-title":"Hematology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"6741","DOI":"10.3390\/molecules27196741","article-title":"Steroid resistance associated with high MIF and P-gp serum levels in SLE patients","volume":"27","author":"Beltr\u00e1n-Ram\u00edrez","year":"2022","journal-title":"Molecules"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e23374","DOI":"10.1002\/jcla.23374","article-title":"Overexpression of P-glycoprotein and resistance to Imatinib in chronic myeloid leukemia patients","volume":"34","author":"Ammar","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.3969\/j.issn.1671-8348.2013.31.017","article-title":"Correlation study on serum Ig levels and adult patients with immune thrombocytopenia","volume":"31","author":"Song","year":"2013","journal-title":"Chongqing Med J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1080\/25785826.2023.2213976","article-title":"Involvement of the complement system in immune thrombocytopenia: review of the literature","volume":"46","author":"Shindo","year":"2023","journal-title":"Immunol Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MBC.0000000000001328","article-title":"The role of eosinophil counts and megakaryocyte nuclei for distinction of acute and chronic immune thrombocytopenic purpura","volume":"36","author":"Cilesiz","year":"2025","journal-title":"Blood Coagul Fibrinolysis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1080\/16078454.2021.2003066","article-title":"Development and validation of a nomogram for steroid-resistance prediction in immune thrombocytopenia patients","volume":"26","author":"Yu","year":"2021","journal-title":"Hematology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e31586","DOI":"10.1002\/pbc.31586","article-title":"Differential expression of BCL2 and IGFBP2 in childhood immune thrombocytopenic Purpura clinical subtypes: implications for predicting disease progression and apoptotic regulation","volume":"72","author":"Bakr","year":"2025","journal-title":"Pediatr Blood Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3906\/sag-1912-242","article-title":"Mean platelet volume and response to the first line therapy in newly diagnosed adult immune thrombocytopenia patients: a retrospective study","volume":"50","author":"Akku\u015f","year":"2020","journal-title":"Turk J Med Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1080\/10245332.2018.1461317","article-title":"Mean platelet volume at baseline and immune thrombocytopenia relapse in Chinese newly-diagnosed patients: a retrospective cohort study","volume":"23","author":"Chen","year":"2018","journal-title":"Hematology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"104161","DOI":"10.1016\/j.drudis.2024.104161","article-title":"P-glycoprotein (P-gp)- driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulators","volume":"29","author":"Guo","year":"2024","journal-title":"Drug Discov Today"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.19405\/j.cnki.issn1000-1492.2019.09.015","article-title":"Expression of CD8+CD28-regulatory T-cells and platelet-specific autoantibody in immune thrombocytopenia","volume":"54","author":"Zhang","year":"2019","journal-title":"Acta Univ Med Anhui"},{"key":"B17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.16571\/j.cnki.2097-2768.2023.01.006","article-title":"Value of systemic immune inflammation index in evaluating disease activity of rheumatoid arthritis","volume":"36","author":"He","year":"2023","journal-title":"J Med Res Combat Trauma Care"},{"key":"B18","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/pbc.22570","article-title":"Initial lymphocyte count and the development of persistent\/chronic immune thrombocytopenic purpura","volume":"55","author":"Ahmed","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7321","DOI":"10.12659\/MSM.916907","article-title":"Platelet to lymphocyte ratio and glucocorticoid resistance in newly diagnosed primary immune thrombocytopenia: a retrospective cohort study","volume":"25","author":"Wang","year":"2019","journal-title":"Med Sci Monit"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1097\/MPH.0000000000002508","article-title":"Re-evaluate the prognostic value of absolute lymphocyte count in pediatric immune thrombocytopenia","volume":"45","author":"Yang","year":"2023","journal-title":"J Pediatr Hematol Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s40262-020-00867-1","article-title":"Effect of P-glycoprotein (P-gp) inducers on exposure of P-gp substrates: review of clinical drug-drug interaction studies","volume":"59","author":"Elmeliegy","year":"2020","journal-title":"Clin Pharmacokinet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3390\/life12060897","article-title":"Multidrug resistance of cancer cells and the vital role of P-glycoprotein","volume":"12","author":"Karthika","year":"2022","journal-title":"Life (Basel)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10238-017-0459-0","article-title":"Serum levels of P-glycoprotein and persistence of disease activity despite treatment in patients with systemic lupus erythematosus","volume":"18","author":"Perez-Guerrero","year":"2018","journal-title":"Clin Exp Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"341","DOI":"10.16138\/j.1673-6087.2020.05.012","article-title":"Relation between glucocorticoid-resistance and P-glycoprotein expression and functional activity in immune thrombocytopenia","volume":"15","author":"Jiang","year":"2020","journal-title":"J Intern Med Concepts Pract"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.3760\/cma.j.cn431274-20230201-00073","article-title":"Analysis of influencing factors for failure of glucocorticoid treatment in immune thrombocytopenia","volume":"25","author":"Li","year":"2023","journal-title":"J Chin Physician"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.13241\/j.cnki.pmb.2023.16.010","article-title":"Study on the correlation between iymphocytes and its subgroups, NK cells and the recurrence of childhood primary immune thrombocytopenia","volume":"23","author":"Li","year":"2023","journal-title":"Prog Mod Biomed"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1182\/blood.2022018380","article-title":"The role of CD8+ T-cell clones in immune thrombocytopenia","volume":"141","author":"Malik","year":"2023","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/ejh.13705","article-title":"T cell-mediated autoimmunity in immune thrombocytopenia","volume":"108","author":"Vrbensky","year":"2022","journal-title":"Eur J Haematol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3760\/cma.j.issn.1673-419X.2016.02.016","article-title":"Mechanism of glucocorticoid efficacy and resistance with chronic immune thrombocytopenia","volume":"39","author":"Liu","year":"2016","journal-title":"Int J Blood Transfus Hematol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.7655\/NYDXBNS20231112","article-title":"Analysis of risk factors for the chronicity of immune thrombocytopenia in children","volume":"43","author":"Cao","year":"2023","journal-title":"J Nanjing Med Univ"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/pbc.24628","article-title":"Absolute lymphocyte counts as prognostic indicators for immune thrombocytopenia outcomes in children","volume":"60","author":"Deel","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"B32","first-page":"660","article-title":"Analysis of prognostic factors of 160 children with immune thrombocytopenia","volume":"54","author":"Liang","year":"2024","journal-title":"Xinjiang Med J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1423-0410.2009.01264.x","article-title":"Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders","volume":"98","author":"Imbach","year":"2010","journal-title":"Vox Sang"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1679463\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T04:10:55Z","timestamp":1759464655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1679463\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":33,"alternative-id":["10.3389\/fped.2025.1679463"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1679463","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"article-number":"1679463"}}